Agent Adds 2 Months to Gastric Ca Survival

January 14, 2014 10:01 PM

4 0

Agent Adds 2 Months to Gastric Ca Survival

SAN FRANCISCO -- Patients with advanced gastric cancer lived 2 months longer when treated with an investigational angiogenesis inhibitor and chemotherapy, a large randomized trial showed.

Median overall survival increased from 7.36 months with chemotherapy alone to 9.63 months with chemotherapy plus ramucirumab. The combination regimen also led to modest but statistically significant improvement in progression-free survival, as reported at the Gastrointestinal Cancers Symposium (GiCS...

Read more

To category page

Loading...